Precision Epigenomics

About:

Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.

Website: http://precision-epigenomics.com

Top Investors: National Institutes of Health

Description:

Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis. They provide clinicians with novel tests and services aimed at improving diagnosis, management, and treatment of medical unmet needs using sophisticated bioinformatics and clinical research. Precision Epigenomics is headquartered in Tucson, Arizona and was founded in 2020.

Total Funding Amount:

$3.12M

Headquarters Location:

Tucson, Arizona, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)precision-epigenomics.com

Founders:

Gary Clarke

Number of Employees:

1-10

Last Funding Date:

2024-08-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai